Matthew Tittler

Goldman Sachs Execution & Clearing LP (GSEC) is an SEC-registered broker/dealer headquartered in New York City and was founded in 1931. The firm is a subsidiary of Goldman Sachs Group, Inc. (NYSE: GS). GSEC provides brokerage services to their clients.

Zazove Associates LLC is a SEC-registered investment advisor headquartered in Incline Village, Nevada with an additional office in Northbrook, Illinois. The firm was founded by Dr. Earl Zazove in 1971 and is a subsidiary of Zazove Associates, Inc. Zazove Associates manages portfolios for a wide variety of clients, which includes insurance companies, public and private pension plans, foundations, endowments, trusts, high net-worth individuals and private investment funds.

UBS AG's (NYSE: UBS) New York City-based wealth management arm is known as UBS Private Banking (US). The firm provides a range of customized wealth management products and services for private clients.

Washington Analysis LLC is an institutional research firm headquartered in Washington, DC. The firm was founded in 1973 and is a subsidiary of Accounting Research & Analytics LLC, which is owned by MSCI, Inc. (NYSE: MSCI). Washington Analysis focuses on anticipating and analyzing changes in public policy that will impact the financial markets. Their expertise lies in assessing investment risks and opportunities arising from legislative, judicial and regulatory developments across the sectors most impacted by policy developments including financial services and housing, healthcare, energy (including utilities/FERC, oil & gas, pipelines and renewables), defense, tax, trade and TMT (tech, media and telecommunications).

Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds.

SDS Capital Group SPC Ltd. is a hedge fund management firm headquartered in Old Greenwich, Connecticut. The firm was founded in 2001 and is a subsidiary of SDS Capital Partners LLC. They offer investment advice to high net-worth individuals and institutional clients.

Guggenheim Securities LLC is a SEC-registered broker-dealer headquartered in New York City. The firm was founded in 1999 and is a subsidiary of Links Holdings LLC, ultimately held by Guggenheim Partners LLC. Guggenheim Securities’ specializations include the sales and trading of fixed-income securities and sophisticated structured products. The firm offers in-depth analysis and expert execution of trading opportunities to large institutional investors and asset originators. They offer sales and trading services relating to a wide range of instruments.

Founded in 2004, TD Securities (USA) LLC is a broker/dealer located in New York City with additional offices in Toronto, Montreal, Calgary, Vancouver, London, Singapore, Tokyo and Sydney. The firm is a subsidiary of Toronto Dominion Holdings (USA), Inc. and their ultimate parent is Toronto-Dominion Bank (NYSE: TD). TD Securities (USA) provides a wide range of capital market products and services to corporate, government and institutional clients in five areas of finance including: investment banking, debt capital markets, institutional equities, foreign exchange and money markets. Their services include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The equity group provides research coverage of media and communications, technology, financial services, oil and gas, mining and metals, industrial products, forest products, technology, utilities and power, real estate, biotechnology, consumer products and merchandising and quantitative analysis strategy. The fixed-income group provides a full range of underwriting sales and trading products for Canadian, U.S. and European debt issuers and investors.

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Accenture LLP provides management consulting, technology, and outsourcing services. Its services encompass customer relationship, finance, human resources, service, supply chain, information management, business process, and infrastructure outsourcing services. The company was founded in 1989 and is headquartered in Chicago, IL.

Saratoga Capital Management LLC (SCM) is an independent, SEC-registered investment advisor headquartered in Avondale, Arizona. Founded in 1994, SCM provides its asset allocation and institutional money management services to investment firms located across the US. The firm delivers its services through the mutual fund family that it manages, the Saratoga Advantage Trust – a group of institutionally managed mutual funds.

Guggenheim Securities LLC (Research) (Guggenheim Securities-RE) is the investment research division of Guggenheim Securities LLC, a financial services firm headquartered in New York City. The firm is a subsidiary of Links Holdings LLC, which is owned by Guggenheim Partners LLC. Guggenheim Securities-RE offers equity research for institutional investors in their research focus sectors: Consumer, Energy & Power, Healthcare, and Technology & Media.

Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010.

Charles Schwab & Co., Inc. is a FINRA-registered broker/dealer headquartered in San Francisco. The firm is a subsidiary of the Charles Schwab Corp. (NYSE: SCHW). They are members of the Chicago Board Options Exchange, NASDAQ and NYSE Arca, Inc. Charles Schwab & Co. is an exchange member engaged in exchange commission business other than floor activities. They also retail mutual funds and OTC corporate equity securities. In addition, the firm underwrites and/or sells corporate securities, underwrites and/or sponsors mutual funds, is a put and call broker/dealer and/or option writer and provides investment advisory services

Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases.

Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY.

Pd Theranostics, Inc. develops algorithms for prostate cancer and diabetic foot ulcers patience. The company is headquartered in New York, NY.

Laidlaw Venture Partners (Laidlaw Venture) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd. The firm is headquartered in New York.

Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY.

Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS.